News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

LPC-001: Cancer Malignancy Longitudinal Project

Study Status:

Open for enrollment

Contact Information:

(956) 362-2384

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

This project is for the longitudinal collection of up to 125 newly diagnosed, treatment naïve cancer patients across three different indications: Colorectal cancer, Breast cancer and Lung Cancer. The expected time frame for this project is 5 years from the date of first enrollment. Specimen collection for this project will include plasma, buffy coat, tumor tissue FFPE blocks and NAT FFPE blocks.


Principal Investigator
Dr. Sohail Rao
Odalys Salinas
Boca Biolistics
Type of Trial
© 2024 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram